Novo Nordisk
-
Business & Finance
Novo Wegovy Faces Fee After Copycat Loss
Wegovy maker novo faces fee demand after losing copycat drug lawsuit – Wegovy maker Novo faces fee demand after losing…
Read More » -
Finance
Parvus Targets Novo Nordisk FT Report
Activist hedge fund Parvus builds stake Novo Nordisk FT reports, sparking immediate interest in the pharmaceutical giant. This move, detailed…
Read More »
